Because it's always nice to put a face to a name, especially in the ephemeral world of cyberspace, I noticed that this month, author (of the $800-Million Pill), blogger and director of integrity in science at the Center for Science in the Public Interest Merrill Goozner was interviewed by CNBC on the subject of FDA's review of cancer drugs. Here is a link to the video on CNBC (click).
He had previously been interviewed last Spring to comment on the New Englnd Journal of Medicine study on physician acceptance of "freebies," in a mini-ebate with PhrMA's Scott Lassman. To view the video, click here.
